Abstract:Cardiac fibrosis accompanies numerous cardiovascular diseases (CVD) such as hypertension and myocardial infarction and increases myocardial stiffness leading to contractile dysfunction. Recently, endothelial-to-mesenchymal transition (EndMT) has been shown to contribute to myocardial fibrosis. EndMT describes a process by which endothelial cells transform into mesenchymal cells such as fibroblasts and has been implicated in many fibrotic diseases. Angiotensin II (AngII) plays a key role in myocardial fibrosis and has been associated with the activation of fibroblasts to myofibroblasts and an increase in myocardial collagen deposition. Here, we assessed the role of AngII in capillary loss and EndMT in vivo and in vitro . C57BL/6J mice were infused with H 2 O (control) or 24μg/kg/hr AngII for 4 weeks. Mice infused with AngII developed significant cardiac fibrosis characterised by the deposition of collagen I (2.5-fold vs. control; p<0.05) and III (1.9-fold vs. control; p<0.05). Capillary density was assessed by CD31 immunohistochemistry and revealed significant vascular rarefaction (control 2161±111 vs . AngII 838±132 capillaries/mm 2 ; p<0.05). To investigate whether AngII can induce EndMT in vitro , human coronary artery endothelial cells were stimulated with 10ng/mL TGFβ 1 alone or in combination with 1μM AngII for 10 days. AngII significantly enhanced TGFβ 1 -induced gene expression of α-smooth muscle actin (TGFβ 1 1.8-fold; TGFβ 1 ±AngII 4.3-fold vs . control; p<0.05) and collagen I (TGFβ 1 9.2-fold; TGFβ 1 +AngII 30.2-fold vs . control; p<0.05). Concomitantly, AngII significantly increased α-smooth muscle actin protein expression (TGFβ 1 3.9-fold; TGFβ 1 +AngII 23.6-fold vs . control; p<0.05) and significantly decreased CD31 expression (TGFβ 1 0.9-fold; TGFβ 1 +AngII 0.7-fold vs . control; p<0.05), suggesting AngII acts in concert with TGFβ 1 to enhance conversion of endothelial cells to myofibroblasts. Further studies investigating the underlying mechanism, including the role of the Smad pathway, are ongoing. These results demonstrate that AngII induces vascular rarefaction in vivo and potentiates TGFβ 1 -induced EndMT in vitro. Understanding the molecular basis for these observations may help to identify new therapeutic options in CVD.

Frataxin Loss Promotes Angiotensin II-Induced Endothelial-to-Mesenchymal Transition

Acetate Controls Endothelial-to-mesenchymal Transition

Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition

Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro

Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis

A6645 Sirtuin 3-Mediated Glycolysis Enhancing During Angiotension II-induced Endothelial-to-mesenchymal Transition

SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin.

Metallothionein Prevents High-Fat Diet-Induced Cardiac Contractile Dysfunction - Role Of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha And Mitochondrial Biogenesis

Metallothionein Prevents High-Fat Diet–Induced Cardiac Contractile Dysfunction

Sirtuin 3 Governs Autophagy‐dependent Glycolysis During Angiotensin II‐induced Endothelial‐to‐mesenchymal Transition

Glycolysis Promotes Angiotensin II–Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1

[bp.08.02] the role of sirt3 mediated endothelial to mesenchymal transition in hypertensive renal fibrosis

A8324 Suppression of Endothelial to Mesenchymal Transition by SIRT3 Alleviated the Development of Hypertensive Renal Injury

Endothelial-Mesenchymal Transition in Heart Failure With a Preserved Ejection Fraction: Insights Into the Cardiorenal Syndrome

Suppression of Endothelial-to-Mesenchymal Transition by SIRT (sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury

Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice

Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARγ and c- Jun

Inflammatory Stress Exacerbates The Progression Of Cardiac Fibrosis In High-Fat-Fed Apolipoprotein E Knockout Mice Via Endothelial-Mesenchymal Transition

Frataxin deficiency promotes endothelial senescence in pulmonary hypertension

Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis

Cardiomyocyte-specific Deletion of Endothelin Receptor A (ETA) Obliterates Cardiac Aging Through Regulation of Mitophagy and Ferroptosis.